Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
JMIR Research Protocols|January 11, 2023
Measurement of Vital Signs by Lifelight Software in Comparison to Standard of Care Multisite Development (VISION-MD): Protocol for an Observational StudyLaura Wiffen, Thomas Brown, Annika Brogaard Maczka, et al.
Advances in Experimental Medicine and Biology|January 20, 2016
A Discussion on the Regulation of Blood Flow and PressureChristopher B Wolff, David J Collier, Mussadiq Shah, et al.
Pacing and Clinical Electrophysiology : PACE|October 18, 2021
Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT programMartin Unverdorben, Christian von Heymann, Amparao Santamaria, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 17, 2024
Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE ProgramMartin Unverdorben, Paolo Colonna, James Jin, et al.
Clinical Cardiology|May 15, 2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE studyPaolo Colonna, Christian von Heymann, Amparo Santamaria, et al.
BDJ Open|August 14, 2023
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE databaseCathy Chen, Manish Saxena, Christian von Heymann, et al.
Cancer Investigation|August 29, 2002
Phase I study of sequential administration of topotecan and 5-fluorouracil in patients with advanced malignanciesEric I Sbar, Jamil Khatri, W David Rodman, et al.
Thrombosis Journal|December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE studyChristian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
European Heart Journal. Digital Health|January 30, 2023
Using social media to recruit study participants for a randomized trial for hypertensionLida Feyz, Yale Wang, Atul Pathak, et al.
JAMA|February 16, 2024
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical TrialGeorge L Bakris, Manish Saxena, Anil Gupta, et al.
Pageof 7